Patents by Inventor Dirk Sartor

Dirk Sartor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE
    Publication number: 20180008558
    Abstract: The present invention relates to extended release compositions of an amino-C2-C6-alkyl nitrate and of pharmaceutically acceptable salt thereof, in particular 2-aminoethyl nitrate, and to fixed dose combinations with further pharmaceutically active drug substances. 2-Aminoethyl nitrate does not provoke nitrate tolerance, but has a very short half life in physiological systems.
    Type: Application
    Filed: September 22, 2017
    Publication date: January 11, 2018
    Applicant: CARDIOLYNX AG
    Inventors: Dirk SARTOR, Pierre VANKAN, Hubert STUCKLER, Armin SCHERHAG
  • EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE
    Publication number: 20170100350
    Abstract: The present invention relates to extended release compositions of an amino-C2-C6-alkyl nitrate and of pharmaceutically acceptable salt thereof, in particular 2-aminoethyl nitrate, and to fixed dose combinations with further pharmaceutically active drug substances. 2-Aminoethyl nitrate does not provoke nitrate tolerance, but has a very short half life in physiological systems.
    Type: Application
    Filed: December 23, 2016
    Publication date: April 13, 2017
    Applicant: CARDIOLYNX AG
    Inventors: Dirk SARTOR, Pierre VANKAN, Hubert STUCKLER, Armin SCHERHAG
  • EXTENDED RELEASE COMPOSITIONS OF AN AMINOALKYL NITRATE
    Publication number: 20150216992
    Abstract: The present invention relates to extended release compositions of an amino-C2-C6-alkyl nitrate and of pharmaceutically acceptable salt thereof, in particular 2-aminoethyl nitrate, and to fixed dose combinations with further pharmaceutically active drug substances. 2-Aminoethyl nitrate does not provoke nitrate tolerance, but has a very short half life in physiological systems.
    Type: Application
    Filed: August 22, 2013
    Publication date: August 6, 2015
    Inventors: Dirk Sartor, Pierre Vankan, Hubert Stuckler, Armin Scherhag
  • Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases
    Patent number: 8729115
    Abstract: Nitrate esters and diazeniumdiolate derivatives of valsartanamide are described. They have valuable properties in the treatment of vascular and metabolic diseases.
    Type: Grant
    Filed: April 18, 2011
    Date of Patent: May 20, 2014
    Assignee: Cardiolynx AG
    Inventors: Dirk Sartor, Armin Scherhag
  • Nitrate and diazeniumdiolate derivatives of pioglitazone
    Patent number: 8703800
    Abstract: Nitrate ester and diazeniumdiolate derivatives of pioglitazone are described. They have valuable properties in the treatment of vascular and metabolic diseases, for example type 2 diabetes.
    Type: Grant
    Filed: June 1, 2011
    Date of Patent: April 22, 2014
    Assignee: Cardiolynx AG
    Inventors: Dirk Sartor, Armin Scherhag
  • Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases
    Patent number: 8426597
    Abstract: Nitrate derivatives of cilostazol are described. They have superior properties and clinical advantages compared to cilostazol in the treatment of vascular and metabolic diseases.
    Type: Grant
    Filed: December 1, 2009
    Date of Patent: April 23, 2013
    Assignee: Cardiolynx AG
    Inventors: Dirk Sartor, Armin Scherhag
  • NITRATE AND DIAZENIUMDIOLATE DERIVATIVES OF PIOGLITAZONE
    Publication number: 20130072525
    Abstract: Nitrate ester and diazeniumdiolate derivatives of pioglitazone are described. They have valuable properties in the treatment of vascular and metabolic diseases, for example type 2 diabetes.
    Type: Application
    Filed: June 1, 2011
    Publication date: March 21, 2013
    Inventors: Dirk Sartor, Armin Scherhag
  • VALSARTAN DERIVATIVES CARRYING NITROGEN OXIDE DONORS FOR THE TREATMENT OF VASCULAR AND METABOLIC DISEASES
    Publication number: 20130041001
    Abstract: Nitrate esters and diazeniumdiolate derivatives of valsartanamide are described. They have valuable properties in the treatment of vascular and metabolic diseases.
    Type: Application
    Filed: April 18, 2011
    Publication date: February 14, 2013
    Inventors: Dirk Sartor, Armin Scherhag
  • NITRATE DERIVATIVES OF CILOSTAZOL FOR THE TREATMENT OF VASCULAR AND METABOLIC DISEASES
    Publication number: 20110230520
    Abstract: Nitrate derivatives of cilostazol are described. They have superior properties and clinical advantages compared to cilostazol in the treatment of vascular and metabolic diseases.
    Type: Application
    Filed: December 1, 2009
    Publication date: September 22, 2011
    Inventors: Dirk Sartor, Armin Scherhag